# Emergex Vaccines Holding

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/emergex-vaccines-holding

- Industry: Biotechnology
- Headquarters: UK
- Website: www.emergexvaccines.com
- Total disclosed funding: $12M
- Latest round: Series A (Sep 3, 2019)
- Investors on record: 2

## About

Founded in 2016 and based in Abingdon, UK, Emergex Vaccines Holding Limited operates as a biopharmaceutical company that provides vaccines for viral and bacterial infectious diseases such as dengue fever, zika, ebola, and pandemic flu.

## Funding rounds

- Series A, Sep 3, 2019, $11M — Vickers Venture Partners
- Seed, Apr 10, 2017, $1.9M — Trend Investment Group

## Investors

- Trend Investment Group (https://capitalatlas.ai/funds/trend-investment-group) — Seed
- Vickers Venture Partners (https://capitalatlas.ai/funds/vickers-venture-partners) — Series A